Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 18 von 90
Journal of nanobiotechnology, 2023-03, Vol.21 (1), p.103-103, Article 103
2023
Volltextzugriff (PDF)

Details

Autor(en) / Beteiligte
Titel
Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics
Ist Teil von
  • Journal of nanobiotechnology, 2023-03, Vol.21 (1), p.103-103, Article 103
Ort / Verlag
England: BioMed Central Ltd
Erscheinungsjahr
2023
Quelle
SpringerLink
Beschreibungen/Notizen
  • Osteosarcoma, the most common malignant tumor of the bone, seriously influences people's lives and increases their economic burden. Conventional chemotherapy drugs achieve limited therapeutic effects owing to poor targeting and severe systemic toxicity. Nanocarrier-based drug delivery systems can significantly enhance the utilization efficiency of chemotherapeutic drugs through targeting ligand modifications and reduce the occurrence of systemic adverse effects. A variety of ligand-modified nano-drug delivery systems have been developed for different targeting schemes. Here we review the biological characteristics and the main challenges of current drug therapy of OS, and further elaborate on different targeting schemes and ligand selection for nano-drug delivery systems of osteosarcoma, which may provide new horizons for the development of advanced targeted drug delivery systems in the future.

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX